Cargando…
Gliptin Accountability in Mucous Membrane Pemphigoid Induction in 24 Out of 313 Patients
Mucous membrane pemphigoids (MMPs) and bullous pemphigoid (BP) are autoimmune bullous diseases that share physiopathological features: both can result from autoantibodies directed against BP180 or BP230 antigens. An association has been reported between BP and intake of gliptins, which are dipeptidy...
Autores principales: | Gaudin, Olivier, Seta, Vannina, Alexandre, Marina, Bohelay, Gérôme, Aucouturier, Françoise, Mignot-Grootenboer, Sabine, Ingen-Housz-Oro, Saskia, Bernardeschi, Céline, Schneider, Pierre, Mellottee, Benoît, Caux, Frédéric, Prost-Squarcioni, Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976795/ https://www.ncbi.nlm.nih.gov/pubmed/29881377 http://dx.doi.org/10.3389/fimmu.2018.01030 |
Ejemplares similares
-
Rapid Disease Control in First-Line Therapy-Resistant Mucous Membrane Pemphigoid and Bullous Pemphigoid with Omalizumab as Add-On Therapy: A Case Series Of 13 Patients
por: Alexandre, Marina, et al.
Publicado: (2022) -
Mucous Membrane Pemphigoid, Bullous Pemphigoid, and Anti-programmed Death-1/ Programmed Death-Ligand 1: A Case Report of an Elderly Woman With Mucous Membrane Pemphigoid Developing After Pembrolizumab Therapy for Metastatic Melanoma and Review of the Literature
por: Zumelzu, Coralie, et al.
Publicado: (2018) -
Rituximab Therapy for Mucous Membrane Pemphigoid: A Retrospective Monocentric Study With Long-Term Follow-Up in 109 Patients
por: Bohelay, Gérôme, et al.
Publicado: (2022) -
Paraneoplastic Pemphigus Revealed by Anti-programmed Death-1 Pembrolizumab Therapy for Cutaneous Squamous Cell Carcinoma Complicating Hidradenitis Suppurativa
por: Yatim, Ahmad, et al.
Publicado: (2019) -
Bullous pemphigoid in diabetic patients treated by gliptins: the other side of the coin
por: Chouchane, Karim, et al.
Publicado: (2021)